Recently we discovered a novel mechanism explaining how B-cell lymphomas might be induced during HIV infections� HIV-positive subjects have an increased risk to develop specific lymphoma subtypes including Burkitt lymphoma (BL)� We recently found that viral transactivator of transcription (Tat) protein, which is released by infected cells into the blood stream, could remodel the B-cell nucleus bringing together the potential translocation partners, the MYC loci at the chromosome 8 and the IGH loci at the chromosome 14, thus increasing the probability of the t(8;14) translocation characteristic of BL� Tat induces the mobility of the MYC locus in the nucleus via induction of DSB in the vicinity of the MYC gene and its further repair by NHEJ� In order to study the mechanism of the DSB/NHEJinduced locus relocalization, we have created and characterized the lymphoblastoid RPMI8866 cell line inducibly expressing CRISPR/Cas9 and gRNA targeting the upstream region of the MYC IGH genes� Upon induction, This leads to relocalization of the MYC locus towards the center of the nucleus and the IGH CRISPR/Cas9 generates DBDs in the target loci as well as t(8;14) transloca-tions� Factors that increase the proximity between the MYC and IGH loci also increase the t(8;14) frequency and inversely, drugs that inhibit proximity also inhibit the translocation frequency. Therefore, we provide here the first experimental proof that spatial proximity indeed increases the probability of chromosomal translocations�
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Dysregulation of splicing factors in B-cell acute lymphoblastic leukemia
Andrei Thomas-Tikhonenko Division of Cancer Pathobiology of the Children's Hospital of Philadelphia and Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA 19104, USA Aberrant splicing is a hallmark of leukemias with mutations in splicing factor (SF)-encoding genes� We investigated its prevalence in pediatric B-cell acute lymphoblastic leukemias (B-ALL), where SFs are not mutated� By comparing them to normal pro-B cells, we found thousands of aberrant local splice variations (LSVs) per sample, with 279 LSVs in 241 genes present in every comparison� These genes were enriched in RNA processing pathways and encoded ~100 SFs, e�g� hnRNPA1� hnRNPA1 3'UTR was most pervasively mis-spliced, yielding the transcript subject to nonsense-mediated decay� To mimic this event, we knocked it down in B-lymphoblastoid cells and identified 213 hnRNPA1-dependent aberrant exon usage events comprising the hnRNPA1 splicing sig-nature in pediatric leukemia� Some of its elements were LSVs in DICER1 and NT5C2, known cancer genes� More broadly, the twenty most common B-ALL drivers (including NT5C2) showed higher prevalence of aberrant splicing than of somatic mutations� Thus, posttranscriptional deregulation of SF can drive widespread changes in B-ALL splicing and likely contributes to disease pathogenesis� doi: http://dx�doi�org/10�7124/bc�0009C8 To study the possible role of cancer testis antigens MAGEA proteins in cellular processes triggering normal cells to cancerous� The specific aim is to characterize MAGEA-positive extracellular vesicles (EVs)� MAGEAs represent a unique class of tumor antigens which are expressed in a wide variety of malignant tumors, while their expression in healthy normal tissues is restricted to germ cells of testis, fetal ovary and placenta� Their restricted expression and immunogenicity make them ideal targets for immunotherapy in human can-cers� MAGEA expression is observed mainly in cancers that have acquired malignant phe-notypes, invasiveness or metastasis, and the expression of MAGEA family proteins has been linked to a poor prognosis in cancer pa-tients� MAGEA proteins have shown to interact ubiquitin ligases and regulate proteasome degradation of proteins, regulate the stability of p53 and interfere with the apoptotic pathway of the cell� Methods: MAGEA-positive EVs are isolated from cell culture media using differential ultracentrifugation and characterized by various biochemical and cellular methods, including western blot analysis, flow cytometry and confocal microscopy� Results: We show that MAGEA proteins are incorporated into extracellular vesicles of different sizes ranging from 150 nm to 2 µm as well as to retrovirus Gag-induced virus-like particles (VLPs)� MAGEA proteins, locating both in the nucleus and cytoplasm of the cell, are directed to the surface of EVs released by cells and furthermore, induce the shedding of cells� MAGEA proteins can also be used to guide recombinant proteins, e�g� EGFP and Cherry, onto the surface of EVs allowing to follow the behavior of EVs in real time� In addition, we show that MAGEA10 expression in mouse fibroblasts induces abnormal phenotypes, where the cell has multiple small nuclei� The mechanism of this phenomena and its biological significance is still not known and needs further investigations� Conclusions: We show that MAGEA proteins are incorporated into EVs and are exposed on the surface of EVs� This process is induced, at least to some extent, by the expression of MAGEA proteins itself and may have a role in formation of cancer metastasis�
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